A panel of experts questioned a local vaccine’s efficacy against the variants of SARS-CoV-2, despite last month agreeing to grant it emergency use authorization, according to the minutes of their meeting.
At the meeting on July 18 of a panel of 21 experts, 18 of the 20 who voted agreed to grant emergency use authorization for the vaccine made by Taiwan-based Medigen Vaccine Biologics Corp without the need for phase 3 clinical trial efficacy data, because the vaccine’s production of antibodies in phase 2 trials met preset standards.
They also felt Medigen’s vaccine was proven to be safe during the phase 2 trials.
Given the emergency facing Taiwan amid the COVID-19 pandemic, they believed the benefits of issuing emergency use authorization to Medigen outweighed the risks, according to the minutes, which were made public on Monday.
However, some experts questioned how effective the vaccine would be in the real world, especially against the Delta and Beta variants of SARS-CoV-2.
Lab tests showed that the vaccine’s antibodies showed better results for some of the early variants of COVID-19, such as the Gamma and D614G variants, but poorer results against the Delta and Beta strains, they said.
They also said that in-vitro lab results might not have a linear relationship to the vaccine’s effectiveness in real life and cautioned against drawing any conclusions from them.
As Taiwanese vaccine makers have yet to conduct phase 3 trials, which are the standard for determining whether a vaccine offers protection against a particular virus, the experts called on Medigen to continue to study its vaccine’s efficacy against new variants and see whether a third dose might be needed.
The experts also urged Medigen to consider conducting phase 3 clinical trails in Taiwan, in addition to its trials on 1,000 people in Paraguay.
The minutes were released after opposition parties requested that the emergency use authorization review process be made public, saying that Taiwanese had been kept in the dark.
The approval was controversial because it was based on two standards set by the Food and Drug Administration (FDA) not found elsewhere in the world: The vaccine must have a seroconversion rate of above 50 percent and geometric mean titers (representing the concentration of virus neutralizing antibodies) at least equal to two-thirds of the level found in recipients of the AstraZeneca vaccine.
The Medigen vaccine had a seroconversion rate of 95.5 percent and generated geometric mean titers that were 3.4 times higher than those found in a control group of 200 people in Taiwan who had received two doses of the AstraZeneca vaccine.
When the FDA on July 18 announced the panel’s vote of 18 in favor of the emergency use authorization, one against and one member wanting more documentation, it did not make any more details public, saying that the meeting was held behind closed doors to allow the experts to express their views freely.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the Central Epidemic Command Center, later agreed to make public the minutes after redacting the names of the experts.
SPACE VETERAN: Kjell N. Lindgren, who helps lead NASA’s human spaceflight missions, has been on two expeditions on the ISS and has spent 311 days in space Taiwan-born US astronaut Kjell N. Lindgren is to visit Taiwan to promote technological partnerships through one of the programs organized by the US for its 250th national anniversary. Lindgren would be in Taiwan from Tuesday to Saturday next week as part of the US Bureau of Educational and Cultural Affairs’ US Speaker Program, organized to celebrate the 250th anniversary of the signing of the Declaration of Independence, the American Institute in Taiwan (AIT) said in a statement yesterday. Lindgren plans to engage with key leaders across the nation “to advance cutting-edge technological partnerships and inspire the next generation of scientists and engineers,”
UNREASONABLE SURVEILLANCE: A camera targeted on an road by a neighbor captured a man’s habitual unsignaled turn into home, netting him dozens of tickets The Taichung High Administrative Court has canceled all 45 tickets given to a man for failing to use a turn signal while driving, as it considered long-term surveillance of his privacy more problematic than the traffic violations. The man, surnamed Tseng (曾), lives in Changhua County and was reported 45 times within a month for failing to signal while driving when he turned into the alley where his residence is. The reports were filed by his neighbor, who set up security cameras that constantly monitored not only the alley but also the door and yard of Tseng’s house. The surveillance occurred from July
A Japan Self-Defense Forces vessel entered the Taiwan Strait yesterday, Japanese media reported. After passing through the Taiwan Strait, the Ikazuchi was to proceed to the South China Sea to take part in a joint military exercise with the US and the Philippines, the reports said. Japan Self-Defense Force vessels were first reported to have passed through the strait in September, 2024, with two further transits taking place in February and June last year, the Asahi Shimbun reported. Yesterday’s transit also marked the first time since Japanese Prime Minister Sanae Takaichi took office that a Japanese warship has been sent through the Taiwan
‘SAME OLD TRICK’: Even if Beijing resumes individual travel to Taiwan, it would only benefit Chinese tourism companies, the Economic Democracy Union convener said China’s 10 new “incentives” are “sugar-coated poison,” an official said yesterday, adding that Taiwanese businesses see them clearly for what they are, but that Beijing would inevitably find some local collaborators to try to drums up support. The official, speaking on condition of anonymity, made the remark ahead of a news conference the General Chamber of Commerce is to hold today. The event, titled “Industry Perspectives on China’s Recent Pro-Taiwan Policies,” is expected to include representatives from industry associations — such as those in travel, hotels, food and agriculture — to request the government cooperate with China’s new measures, people familiar with
RSS